Saxenda Weight Loss Injection – FDA-Approved GLP-1 for Appetite Control

Saxenda® (liraglutide) is an FDA-approved prescription weight loss injection for chronic weight management in adults and adolescents (12+) with obesity or overweight with a related condition. Saxenda is a GLP-1 receptor agonist that helps reduce appetite, slow digestion, and increase fullness—leading to lower calorie intake and sustainable weight loss when combined with diet and exercise.

How Saxenda Works

Saxenda mimics the GLP-1 hormone, which regulates hunger and satiety. It supports weight loss by:

Decreasing appetite and cravings

Slowing stomach emptying

Promoting longer-lasting fullness

Dosage & Use

Saxenda is taken as a once-daily injection using a prefilled pen. Treatment begins at 0.6 mg daily and increases gradually to a 3 mg maintenance dose to reduce side effects. Injections are given in the abdomen, thigh, or upper arm.

Side Effects & Safety

Common side effects include nausea, diarrhea, constipation, vomiting, headache, fatigue, and injection site reactions. Saxenda carries an FDA boxed warning for thyroid C-cell tumors (seen in animal studies) and should not be used by patients with medullary thyroid carcinoma (MTC) or MEN 2. Rare risks include pancreatitis, gallbladder disease, kidney problems, and increased heart rate.

Cost & Availability

Saxenda pricing without insurance averages $1,300+ per month. Insurance coverage, savings programs, and telehealth weight loss services may reduce costs. Patients should avoid unapproved or counterfeit versions.

Saxenda vs. Wegovy

Compared to Wegovy or Ozempic (semaglutide), Saxenda requires daily injections and typically results in moderate weight loss, while weekly GLP-1 injections often produce greater average weight loss.

Weight Loss Injections provides trusted access to Saxenda weight loss injections online, with licensed U.S. providers, telehealth evaluations, and nationwide delivery.